Epstein-Barr Virus Nuclear Antigen 3C Facilitates G1-S Transition by Stabilizing and Enhancing the Function of Cyclin D1

English version České info

EBNA3C, one of the Epstein-Barr virus (EBV)-encoded latent antigens, is essential for primary B-cell transformation. Cyclin D1, a key regulator of G1 to S phase progression, is tightly associated and aberrantly expressed in numerous human cancers. Previously, EBNA3C was shown to bind to Cyclin D1 in vitro along with Cyclin A and Cyclin E. In the present study, we provide evidence which demonstrates that EBNA3C forms a complex with Cyclin D1 in human cells. Detailed mapping experiments show that a small N-terminal region which lies between amino acids 130–160 of EBNA3C binds to two different sites of Cyclin D1- the N-terminal pRb binding domain (residues 1–50), and C-terminal domain (residues 171–240), known to regulate Cyclin D1 stability. Cyclin D1 is short-lived and ubiquitin-mediated proteasomal degradation has been targeted as a means of therapeutic intervention. Here, we show that EBNA3C stabilizes Cyclin D1 through inhibition of its poly-ubiquitination, and also increases its nuclear localization by blocking GSK3β activity. We further show that EBNA3C enhances the kinase activity of Cyclin D1/CDK6 which enables subsequent ubiquitination and degradation of pRb. EBNA3C together with Cyclin D1-CDK6 complex also efficiently nullifies the inhibitory effect of pRb on cell growth. Moreover, an sh-RNA based strategy for knock-down of both cyclin D1 and EBNA3C genes in EBV transformed lymphoblastoid cell lines (LCLs) shows a significant reduction in cell-growth. Based on these results, we propose that EBNA3C can stabilize as well as enhance the functional activity of Cyclin D1 thereby facilitating the G1-S transition in EBV transformed lymphoblastoid cell lines.

Vyšlo v časopise: Epstein-Barr Virus Nuclear Antigen 3C Facilitates G1-S Transition by Stabilizing and Enhancing the Function of Cyclin D1. PLoS Pathog 7(2): e32767. doi:10.1371/journal.ppat.1001275
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1001275

Souhrn

Zdroje

1. RobertsonES

2010

Epstein-Barr virus: latency and transformation.

Norwich, United Kingdom

Caister Academic Press

2. KieffE

RickinsonAB

2002

Epstein-Barr virus and its replication.

KnipeD

HowleyP

Fields virology, 4th ed

Philadelphia

Lippincott Williams & Wilkins

2511

2573

3. O'NionsJ

AlldayMJ

2004

Deregulation of the cell cycle by the Epstein-Barr virus.

Adv Cancer Res

119

186

4. BajajBG

MurakamiM

CaiQ

VermaSC

LanK

2008

Epstein-Barr virus nuclear antigen 3C interacts with and enhances the stability of the c-Myc oncoprotein.

J Virol

4082

4090

5. BainM

WatsonRJ

FarrellPJ

AlldayMJ

1996

Epstein-Barr virus nuclear antigen 3C is a powerful repressor of transcription when tethered to DNA.

J Virol

2481

2489

6. RosendorffA

IllanesD

DavidG

LinJ

KieffE

2004

EBNA3C coactivation with EBNA2 requires a SUMO homology domain.

J Virol

367

377

7. CotterMA2nd

RobertsonES

2000

Modulation of histone acetyltransferase activity through interaction of epstein-barr nuclear antigen 3C with prothymosin alpha.

Mol Cell Biol

5722

5735

8. KnightJS

LanK

SubramanianC

RobertsonES

2003

Epstein-Barr virus nuclear antigen 3C recruits histone deacetylase activity and associates with the corepressors mSin3A and NCoR in human B-cell lines.

J Virol

4261

4272

9. TouitouR

HickabottomM

ParkerG

CrookT

AlldayMJ

2001

Physical and functional interactions between the corepressor CtBP and the Epstein-Barr virus nuclear antigen EBNA3C.

J Virol

7749

7755

10. SubramanianC

CotterMA2nd

RobertsonES

2001

Epstein-Barr virus nuclear protein EBNA-3C interacts with the human metastatic suppressor Nm23-H1: a molecular link to cancer metastasis.

Nat Med

350

355

11. YanX

MouilletJF

OuQ

SadovskyY

2003

A novel domain within the DEAD-box protein DP103 is essential for transcriptional repression and helicase activity.

Mol Cell Biol

414

423

12. KnightJS

SharmaN

RobertsonES

2005

SCFSkp2 complex targeted by Epstein-Barr virus essential nuclear antigen.

Mol Cell Biol

1749

1763

13. SubramanianC

HasanS

RoweM

HottigerM

OrreR

2002

Epstein-Barr virus nuclear antigen 3C and prothymosin alpha interact with the p300 transcriptional coactivator at the CH1 and CH3/HAT domains and cooperate in regulation of transcription and histone acetylation.

J Virol

4699

4708

14. YiF

SahaA

MurakamiM

KumarP

KnightJS

2009

Epstein-Barr virus nuclear antigen 3C targets p53 and modulates its transcriptional and apoptotic activities.

Virology

388

236

247

15. KnightJS

RobertsonES

2004

Epstein-Barr virus nuclear antigen 3C regulates cyclin A/p27 complexes and enhances cyclin A-dependent kinase activity.

J Virol

1981

1991

16. KnightJS

SharmaN

KalmanDE

RobertsonES

2004

A cyclin-binding motif within the amino-terminal homology domain of EBNA3C binds cyclin A and modulates cyclin A-dependent kinase activity in Epstein-Barr virus-infected cells.

J Virol

12857

12867

17. KnightJS

SharmaN

RobertsonES

2005

Epstein-Barr virus latent antigen 3C can mediate the degradation of the retinoblastoma protein through an SCF cellular ubiquitin ligase.

Proc Natl Acad Sci U S A

102

18562

18566

18. SahaA

MurakamiM

KumarP

BajajB

SimsK

2009

Epstein-Barr virus nuclear antigen 3C augments Mdm2-mediated p53 ubiquitination and degradation by deubiquitinating Mdm2.

J Virol

4652

4669

19. ChoudhuriT

VermaSC

LanK

MurakamiM

RobertsonES

2007

The ATM/ATR signaling effector Chk2 is targeted by Epstein-Barr virus nuclear antigen 3C to release the G2/M cell cycle block.

J Virol

6718

6730

20. ParkerGA

CrookT

BainM

SaraEA

FarrellPJ

1996

Epstein-Barr virus nuclear antigen (EBNA)3C is an immortalizing oncoprotein with similar properties to adenovirus E1A and papillomavirus E7.

Oncogene

2541

2549

21. ParkerGA

TouitouR

AlldayMJ

2000

Epstein-Barr virus EBNA3C can disrupt multiple cell cycle checkpoints and induce nuclear division divorced from cytokinesis.

Oncogene

700

709

22. BloomJ

CrossFR

2007

Multiple levels of cyclin specificity in cell-cycle control.

Nat Rev Mol Cell Biol

149

160

23. BaldinV

LukasJ

MarcoteMJ

PaganoM

DraettaG

1993

Cyclin D1 is a nuclear protein required for cell cycle progression in G1.

Genes Dev

812

821

24. BenzenoS

LuF

GuoM

BarbashO

ZhangF

2006

Identification of mutations that disrupt phosphorylation-dependent nuclear export of cyclin D1.

Oncogene

6291

6303

25. GansaugeS

GansaugeF

RamadaniM

StobbeH

RauB

1997

Overexpression of cyclin D1 in human pancreatic carcinoma is associated with poor prognosis.

Cancer Res

1634

1637

26. LinDI

BarbashO

KumarKG

WeberJD

HarperJW

2006

Phosphorylation-dependent ubiquitination of cyclin D1 by the SCF(FBX4-alphaB crystallin) complex.

Mol Cell

355

366

27. DiehlJA

ChengM

RousselMF

SherrCJ

1998

Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization.

Genes Dev

3499

3511

28. CampoE

RaffeldM

JaffeES

1999

Mantle-cell lymphoma.

Semin Hematol

115

127

29. YatabeY

NakamuraS

SetoM

KurodaH

KagamiY

1996

Clinicopathologic study of PRAD1/cyclin D1 overexpressing lymphoma with special reference to mantle cell lymphoma. A distinct molecular pathologic entity.

Am J Surg Pathol

1110

1122

30. NakagawaH

WangTC

ZukerbergL

OdzeR

TogawaK

1997

The targeting of the cyclin D1 oncogene by an Epstein-Barr virus promoter in transgenic mice causes dysplasia in the tongue, esophagus and forestomach.

Oncogene

1185

1190

31. KimJK

DiehlJA

2009

Nuclear cyclin D1: an oncogenic driver in human cancer.

J Cell Physiol

220

292

296

32. PalmeroI

HolderA

SinclairAJ

DicksonC

PetersG

1993

Cyclins D1 and D2 are differentially expressed in human B-lymphoid cell lines.

Oncogene

1049

1054

33. MeyyappanM

WongH

HullC

RiabowolKT

1998

Increased expression of cyclin D2 during multiple states of growth arrest in primary and established cells.

Mol Cell Biol

3163

3172

34. SinclairAJ

PalmeroI

PetersG

FarrellPJ

1994

EBNA-2 and EBNA-LP cooperate to cause G0 to G1 transition during immortalization of resting human B lymphocytes by Epstein-Barr virus.

EMBO J

3321

3328

35. KimHR

JeongJA

ParkCH

LeeSK

LeeWK

2002

A role for cell cycle proteins in the serum-starvation resistance of Epstein-Barr virus immortalized B lymphocytes.

Biochem Cell Biol

407

413

36. ParkCH

KimHR

KimJ

JangSH

LeeKY

2004

Latent membrane protein 1 of Epstein-Barr virus plays an important role in the serum starvation resistance of Epstein-Barr virus-immortalized B lymphocytes.

J Cell Biochem

777

785

37. MuraiY

DobashiY

OkadaE

IshizawaS

ShiotaM

2001

Study on the role of G1 cyclins in Epstein-Barr virus-associated human lymphomas maintained in severe combined immune deficiency (SCID) mice.

Int J Cancer

232

239

38. LuJ

VermaSC

MurakamiM

CaiQ

KumarP

2009

Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus (KSHV) upregulates survivin expression in KSHV-Associated B-lymphoma cells and contributes to their proliferation.

J Virol

7129

7141

39. PontenJ

SakselaE

1967

Two established in vitro cell lines from human mesenchymal tumours.

Int J Cancer

434

447

40. HalderS

MurakamiM

VermaSC

KumarP

YiF

2009

Early events associated with infection of Epstein-Barr virus infection of primary B-cells.

PLoS One

e7214

41. LaemmliUK

1970

Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Nature

227

680

685

42. KlierM

AnastasovN

HermannA

MeindlT

AngermeierD

2008

Specific lentiviral shRNA-mediated knockdown of cyclin D1 in mantle cell lymphoma has minimal effects on cell survival and reveals a regulatory circuit with cyclin D2.

Leukemia

2097

2105

43. O'NionsJ

AlldayMJ

2003

Epstein-Barr virus can inhibit genotoxin-induced G1 arrest downstream of p53 by preventing the inactivation of CDK2.

Oncogene

7181

7191

44. MaruoS

WuY

IshikawaS

KandaT

IwakiriD

2006

Epstein-Barr virus nuclear protein EBNA3C is required for cell cycle progression and growth maintenance of lymphoblastoid cells.

Proc Natl Acad Sci U S A

103

19500

19505

45. ArvanitakisL

YaseenN

SharmaS

1995

Latent membrane protein-1 induces cyclin D2 expression, pRb hyperphosphorylation, and loss of TGF-beta 1-mediated growth inhibition in EBV-positive B cells.

J Immunol

155

1047

1056

46. SiegertJL

RushtonJJ

SellersWR

KaelinWGJr

RobbinsPD

2000

Cyclin D1 suppresses retinoblastoma protein-mediated inhibition of TAFII250 kinase activity.

Oncogene

5703

5711

47. ZwickerJ

BrusselbachS

JoossKU

SewingA

BehnM

1999

Functional domains in cyclin D1: pRb-kinase activity is not essential for transformation.

Oncogene

48. ZhouY

LiJ

XuK

HuSX

BenedictWF

1994

Further characterization of retinoblastoma gene-mediated cell growth and tumor suppression in human cancer cells.

Proc Natl Acad Sci U S A

4165

4169

49. MaruoS

WuY

ItoT

KandaT

KieffED

2009

Epstein-Barr virus nuclear protein EBNA3C residues critical for maintaining lymphoblastoid cell growth.

Proc Natl Acad Sci U S A

106

4419

4424

50. JaresP

FernandezPL

CampoE

NadalA

BoschF

1994

PRAD-1/cyclin D1 gene amplification correlates with messenger RNA overexpression and tumor progression in human laryngeal carcinomas.

Cancer Res

4813

4817

51. BartkovaJ

LukasJ

MullerH

StraussM

GustersonB

1995

Abnormal patterns of D-type cyclin expression and G1 regulation in human head and neck cancer.

Cancer Res

949

956

52. BuckleyMF

SweeneyKJ

HamiltonJA

SiniRL

ManningDL

1993

Expression and amplification of cyclin genes in human breast cancer.

Oncogene

2127

2133

53. WilliamsME

SwerdlowSH

RosenbergCL

ArnoldA

1992

Characterization of chromosome 11 translocation breakpoints at the bcl-1 and PRAD1 loci in centrocytic lymphoma.

Cancer Res

5541s

5544s

54. MotokuraT

BloomT

KimHG

JuppnerH

RudermanJV

1991

A novel cyclin encoded by a bcl1-linked candidate oncogene.

Nature

350

512

515

55. LovecH

SewingA

LucibelloFC

MullerR

MoroyT

1994

Oncogenic activity of cyclin D1 revealed through cooperation with Ha-ras: link between cell cycle control and malignant transformation.

Oncogene

323

326

56. GaniatsasS

DowR

ThompsonA

SchulmanB

GermainD

2001

A splice variant of Skp2 is retained in the cytoplasm and fails to direct cyclin D1 ubiquitination in the uterine cancer cell line SK-UT.

Oncogene

3641

3650

57. YuZK

GervaisJL

ZhangH

1998

Human CUL-1 associates with the SKP1/SKP2 complex and regulates p21(CIP1/WAF1) and cyclin D proteins.

Proc Natl Acad Sci U S A

11324

11329

58. AlaoJP

LamEW

AliS

BuluwelaL

BordognaW

2004

Histone deacetylase inhibitor trichostatin A represses estrogen receptor alpha-dependent transcription and promotes proteasomal degradation of cyclin D1 in human breast carcinoma cell lines.

Clin Cancer Res

8094

8104

59. PontanoLL

DiehlJA

2008

Speeding through cell cycle roadblocks: Nuclear cyclin D1-dependent kinase and neoplastic transformation.

Cell Div

60. SherrCJ

1996

Cancer cell cycles.

Science